The peroxisome proliferator-activated receptor-γ 2 (PPAR-γ 2) Pro12Ala polymorphism is associated with decreased risk of advanced diabetic nephropathy in patients with type 2 diabetes mellitus (DM2)

被引：0
|
作者：
Caramori, ML
Canani, LH
Costa, L
Gross, JL
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [1] The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes
    Caramori, ML
    Canani, LH
    Costa, LA
    Gross, JL
    DIABETES, 2003, 52 (12) : 3010 - 3013
  • [2] The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Andersen, G
    Ek, J
    Urhammer, SA
    Eiberg, H
    Borch-Johnsen, K
    Hansen, T
    Pedersen, O
    DIABETOLOGIA, 2000, 43 : A87 - A87
  • [3] Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes
    Pollex, Rebecca L.
    Mamakeesick, Mary
    Zinman, Bernard
    Harris, Stewart B.
    Hegele, Robert A.
    Hanley, Anthony J. G.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 166 - 171
  • [4] Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes -: The Berlin Diabetes Mellitus (BeDiaM) Study
    Herrmann, SM
    Ringel, J
    Wang, JG
    Staessen, JA
    Brand, E
    DIABETES, 2002, 51 (08) : 2653 - 2657
  • [5] Peroxisome proliferator-activated receptor-γ2 (PPARγ) polymorphism Pro12Ala and diabetic nephropathy in Type 1 diabetic patients in the FinnDiane Study
    Forsblom, CM
    Fröjdö, S
    Parkkonen, M
    Pettersson-Fernholm, K
    Fagerudd, J
    Groop, PH
    DIABETOLOGIA, 2003, 46 : A334 - A335
  • [6] The peroxisome proliferator-activated receptor-γ2 pro12Ala polymorphism
    Stumvoll, M
    Häring, H
    DIABETES, 2002, 51 (08) : 2341 - 2347
  • [7] Peroxisome proliferator activated receptor polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes mellitus
    Herrmann, SM
    Ringel, J
    Wang, JG
    Staessen, JA
    Brand, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R115 - R115
  • [8] Peroxisome proliferator activated receptor polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes mellitus
    Herrmann, SM
    Ringel, J
    Wang, JG
    Staessen, JA
    Brand, E
    JOURNAL OF HYPERTENSION, 2002, 20 : S26 - S26
  • [9] Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Mancini, FP
    Vaccaro, O
    Sabatino, L
    Tufano, A
    Rivellese, AA
    Riccardi, G
    Colantuoni, V
    DIABETES, 1999, 48 (07) : 1466 - 1468
  • [10] Peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes
    Lee, Byung Cheol
    Lee, Hye-jung
    Chung, Joo-Ho
    NEUROSCIENCE LETTERS, 2006, 410 (02) : 141 - 145
12345